Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science Kigali, Rwanda July 13-17 Back

Long-acting cabotegravir and rilpivirine in adults with suboptimal HIV control in sub-Saharan Africa: the IMPALA trial 48-week results       IAS 2025   IAS 2025 July 13-17 Rwanda   ( F. CRESSWELL )